Lataa...
Suramin Inhibits Osteoarthritic Cartilage Degradation by Increasing Extracellular Levels of Chondroprotective Tissue Inhibitor of Metalloproteinases 3
Osteoarthritis is a common degenerative joint disease for which no disease-modifying drugs are currently available. Attempts to treat the disease with small molecule inhibitors of the metalloproteinases that degrade the cartilage matrix have been hampered by a lack of specificity. We aimed to inhibi...
Tallennettuna:
| Julkaisussa: | Mol Pharmacol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5588548/ https://ncbi.nlm.nih.gov/pubmed/28798097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.117.109397 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|